HUMANE THERAPEUTIKA

European patent · EP3188721 · In force

Register entry

Publication number
EP3188721
Application number
EP15853030
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 16, 2015
Published
Jul 12, 2017
Granted
Jun 12, 2019
Protection ends at the latest
Oct 15, 2035
Next annual fee due
Oct 31, 2026
IPC classes
A61K 45/06 (2006.01)
A61K 31/11 (2006.01)
A61K 31/121 (2006.01)
A61K 31/437 (2006.01)
A61P 35/00 (2006.01)
Priority
US 201462066686 P 21.10.2014
US 201562161090 P 13.05.2015
US 201514721011 26.05.2015
US 201562184051 P 24.06.2015
PCT application
PCT/US2015/055968 16.10.2015
PCT publication
WO2016/064676 28.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 17, 2022

    Change

    Published in Swissreg on 17.11.2022

  5. May 16, 2022

    Address changed

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 16.05.2022

  6. Aug 6, 2019

    Agent entered

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 06.08.2019

  7. Jun 12, 2019

    Granted

    Published in Swissreg on 12.06.2019

Parties

Inventor

ZAID, Gene H.

Sterling, Kansas 67579, US

BURGOYNE, Thomas W.

Sterling, Kansas 67579, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.